Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
BBNX
$19.34
+5.11%
BBNX
· Beta Bionics, Inc.
$19.34
+0.94 (+5.11%)
At close · Oct 22
Return incl. dividend (before tax)
Market Cap
$868.30M
Shares
44.99M
Volume · Oct 22
685.22K
Avg daily vol (3M)
1.29M
All webcasts
Earnings call · FY2026 Q2
Beta Bionics, Inc. (BBNX) Q2 2026 Earnings Call
Revenue
$32.01M
+37.8% YoY
Diluted EPS
-$0.53
Gross margin
59.0%
+5.2 pp YoY
Net income
-$23.40M
Forward guidance
3 guided metrics
Management's latest ranges and targets are included below.
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Research materials
Open the source you need; every reader stays inside this workspace.
Forward guidance
From the 8-K filed Jul 29, 2026.
| Metric | Period | Guided | Basis |
|---|---|---|---|
|
Estimated total revenue
Maintained
2026 Full Year Guidance
|
$131M – $136M | — | |
|
Estimated gross margin
Raised
2026 Full Year Guidance
|
58.5% – 59.5% | — | |
|
Estimated 37% to 39% of new patient starts reimbursed through th
2026 Full Year Guidance
|
37% – 39% | — |
SEC filing · Item 2.02
8-K earnings release
Filed Jul 29, 2026 · complete as-filed document
SEC periodic report
10-Q report
Filed Jul 29, 2026 · complete as-filed document